Gr1+IL-4-producing innate cells are induced in response to Th2 stimuli and suppress Th1-dependent antibody responses by McKee, Amy S. et al.
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk 
 
 
 
 
 
 
 
McKee, A.S., MacLeod, M.K.L., White, J., Crawford, F., Kappler, J.W., 
and Marrack, P. (2008) Gr1+IL-4-producing innate cells are induced in 
response to Th2 stimuli and suppress Th1-dependent antibody 
responses. International Immunology, 20 (5). pp. 659-669. ISSN 0953-
8178 
 
 
 
 
 
 
http://eprints.gla.ac.uk/70312/ 
 
 
 
 
Deposited on: 4 October 2012 
 
 
International Immunology, Vol. 20, No. 5, pp. 659–669
doi:10.1093/intimm/dxn025
ª The Author 2008. Published by Oxford University Press on behalf of
The Japanese Society for Immunology. All rights reserved.
Gr11IL-4-producing innate cells are induced in
response to Th2 stimuli and suppress Th1-dependent
antibody responses
Amy S. McKee1, Megan MacLeod1, Janice White1, Frances Crawford1, John W. Kappler1,2,3 and
Philippa Marrack1,3,4
1Integrated Department of Immunology, National Jewish Medical and Research Center, Howard Hughes Medical Institute, 1400
Jackson Street, CO 80206, USA
2Department of Pharmacology, 3Department of Medicine, University of Colorado Health Science Center, Denver, CO 80262, USA
and 4Program in Biomolecular Structure, Department of Biochemistry and Molecular Genetics
Keywords: antibodies, helminth, T cells, Th2, vaccine adjuvant
Abstract
Alum is used as a vaccine adjuvant and induces Th2 responses and Th2-driven antibody isotype
production against co-injected antigens. Alum also promotes the appearance in the spleen of Gr11
IL-41 innate cells that, via IL-4 production, induce MHC II-mediated signaling in B cells. To investigate
whether these Gr11 cells accumulate in the spleen in response to other Th2-inducing stimuli and to
understand some of their functions, the effects of injection of alum and eggs from the helminth,
Schistosoma mansoni, were compared. Like alum, schistosome eggs induced the appearance of
Gr11IL-41 cells in spleen and promoted MHC II-mediated signaling in B cells. Unlike alum, however,
schistosome eggs did not promote CD4 T cell responses against co-injected antigens, suggesting
that the effects of alum or schistosome eggs on splenic B cells cannot by themselves explain the
T cell adjuvant properties of alum. Accordingly, depletion of IL-4 or Gr11 cells in alum-injected mice
had no effect on the ability of alum to improve expansion of primary CD4 T cells. However, Gr11 cells
and IL-4 played some role in the effects of alum, since depletion of either resulted in antibody
responses to antigen that included not only the normal Th2-driven isotypes, like IgG1, but also
a Th1-driven isotype, IgG2c. These data suggest that alum affects the immune response in at least two
ways: one, independent of Gr11 cells and IL-4, that promotes CD4 T cell proliferation and another, via
Gr11IL-41 cells, that participates in the polarization of the response.
Introduction
Recently, there has been a tremendous increase in the un-
derstanding of the innate immune system and its impact on
specific immunity. Among the subjects that have received
a great deal of attention are adjuvants, the means by which
they activate innate immunity and the consequences of this
activation for antigen-specific T and B cells. Adjuvants great-
ly improve specific immune responses by increasing the
numbers of antigen-specific T and B cells, by increasing the
titers of antibody made and by increasing the numbers of
T and B cells that convert to memory cells (1, 2). Under-
standing how adjuvants work will enhance our understand-
ing for the development of effective vaccines.
Some vaccines contain endogenous adjuvants in the form
of microbial molecules. The innate immune system uses
pattern recognition receptors such as Toll-like receptors
(TLRs) to broadly recognize molecules produced by invad-
ing organisms (3–5). Once engaged, directly or indirectly,
by ligands, TLRs promote responses in innate cells that
have the potential to affect developing adaptive immune
responses. TLR ligands potently activate dendritic cells
(DCs) to process antigen and up-regulate co-stimulatory
molecules and cytokines to provide the required signals to
activate naive T cells (6). Different adjuvants stimulate differ-
ent responses from DCs and innate cells, and consequently
the nature of the specific immune response to antigen is af-
fected by the adjuvant present at the time (7).
Many vaccines contain alum, a TLR-independent adjuvant
that induces Th2-polarized responses (8–10). Probably
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because of the bias in the type of Tcell induced, alum markedly
improves IgG1 and IgE response against co-injected antigens
and suppresses production of antibody isotypes associated
with Th1 responses such as IgG2a/c (10, 11). Like alum, some
infectious agents make T cells differentiate into Th2 cells. Most
notable among these are the helminths, including the eggs of
the trematode worm, Schistosoma mansoni. Schistosoma
mansoni eggs induce very powerful Th2 responses and high
titers of antibody of the isotypes, which are stimulated by
Th2, cytokines including IgG1 and IgE (12, 13).
Surprisingly, little is known about how alum and other Th2-
driving substances are recognized by the body or how they
act as adjuvants on the adaptive immune response in vivo.
Unlike adjuvants that promote Th1 responses, Th2-promoting
adjuvants do not induce DCs to produce Th1-polarizing cyto-
kines such as IL-12 (7,14–16). Moreover, alum does not fully
activate DCs in vitro, although it does induce caspase 1 acti-
vation and release of IL-1b and IL-18 cytokines by these
cells, a property that may contribute to the effects of alum
on CD4 cells in vivo (17–19). Alum may also directly en-
hance antigen presentation as DCs pulsed with alum-
adsorbed antigen prime CD4 cells in vitro more effectively
than DCs pulsed with soluble antigen do (20).
In vivo, Th2 responses can develop in the absence of IL-4
and IL-4/ mice injected with alum-containing adjuvants
are able to mount robust Th2 responses (21–24). However,
in the absence of IL-4 or IL-4 receptor signaling, Th1
responses and Th1-dependent antibody isotypes also occur
(23, 24). Thus, IL-4 plays an important role in suppressing
Th1 development and for ultimately biasing the immune re-
sponse against antigens with which alum is co-injected. In
the primary response to alum-adsorbed antigen, IL-4 sup-
presses Tbet expression and Th1 responses as early as day
3 following injection, yet the means by which alum makes
T cells differentiate into Th2 cells remain unknown (25).
Although large numbers of CD4 cells themselves produce
IL-4 during the primary response against alum-adsorbed an-
tigen (26), it is clear that other innate cells in the spleen also
express IL-4 in an antigen-independent manner (27). The
relative importance of innate versus CD4 cell-derived IL-4 in
the suppression of type 1 responses to alum-adsorbed anti-
gen has not been dissected in vivo.
We have shown that increased numbers of innate, IL-4-
expressing cells are detected in the spleen after exposure
to alum (27). Two types of cells fall into this category, one
expressing intermediate levels of Gr1 (Gr1+) and another
population that is Gr1 negative (Gr1). After alum injection,
Gr1+ cells are found in the red pulp of the spleen and near
B cell follicles and IL-4-expressing cells in this population
‘prime’ B cells to respond to cross-linking of their MHC II
proteins by fluxing calcium (Ca2+) rather than dying, the fate
of a non-primed B cell on which MHC II has been cross-
linked (27, 28). To find out whether the appearance of these
cells is unique to alum exposure, we tested whether S. mansoni
eggs, a natural Th2 stimulus, would also cause the appear-
ance of innate IL-4-producing cells and consequent effects
on MHC II-mediated signaling in splenic B cells. Here, we
show that, like alum, S. mansoni eggs cause Gr1 and
Gr1+ IL-4-producing cells to appear in spleen. Like the
cells induced by alum, the egg-induced Gr1-expressing
cells promote enhanced Ca2+ fluxes in splenic B cells stimu-
lated through their MHC II molecules. Alum greatly enhances
expansion of antigen-specific CD4 cells to co-injected anti-
gen while S. mansoni eggs do not. Thus, alum has several
adjuvant effects, some of which occur by separate mecha-
nisms. Enhanced expansion of antigen-specific CD4 cells to
antigen co-injected with alum and the development of a Th2
response was independent of IL-4- and Gr1-expressing
cells, but Th1 responses were enhanced when mice were
treated with Gr1- or IL-4-depleting antibodies. This suggests
that IL-4-expressing Gr1+ cells play a role in suppressing
type 1 immune responses potentiated by alum.
Methods
Mice
Female BALB/c and C57Bl/6 wild-type (WT) mice were
obtained from The Jackson Laboratories. IL-4/ mice on
a B6 background were kindly provided by Erwin Gelfand at
National Jewish Medical and Research Center. Green fluo-
rescence protein (GFP) IL-4 reporter (4Get) mice on BALB/c
and C57Bl/6 backgrounds were a gift from Richard Locksley
at University of California at San Francisco Medical Center.
IL-4 reporter mice and IL-4/ were bred and maintained
in a specific pathogen-free environment at the Animal Care
Facility at National Jewish Biological Resource Center. All
animals were housed and maintained in accordance with
the research guidelines of the Institutional Animal Care and
Use Committee.
Antibodies and reagents
mAbs against Gr1 (RB6-8C5), IL-4 (11B11), IAb/d (MKD6
and D3.137), IAb (Y3P) and FccRIII/II (2.4G2) were purified
from hybridoma supernatants in our laboratory. Alexa Fluor
(AF) 408 was conjugated to Y3P antibodies using the AF408
protein conjugation kit (Molecular Probes). The following
fluorochrome-labeled mAbs were purchased from BD Phar-
Mingen: Allophytocyanin (APC)–Cy7 anti-CD4 (GK1.5), APC
anti-CD44 (IM7), PE anti-B220 (RA3-6B2), PE-conjugated
anti-IAb (AF6-120.1) and PE- and PerCP-labeled anti-Gr1
(RB6-8C5). Pacific blue (PB)-conjugated anti-Gr1 (RB6-
8C5), F480 (BM9), B220 (RA3-6B2) and PE–Cy5-labeled
anti-CD3 mAb (145-2C11) were purchased from eBioscien-
ces. A647-labeled F480 (C1:A3-1) was from Serotec, PE-
labeled anti-CCR3 (83101) was from R&D Systems and
indo-1AM dye was purchased from Calbiochem. Alkaline
phosphatase-conjugated antibodies against mouse IgG1
and IgG2c heavy chains were purchased from Southern Bio-
tech. Chicken egg ovalbumin (OVA) protein for antibody
experiments was purchased from Sigma or was from the
Imject Maleimide. Activated OVA Kit (Pierce Biotechnology,
Inc.) and was conjugated to a cysteine-linked 3K peptide
(FEAQKAKANKAVDGGGC) (prepared at The Molecular
Resources Center at the National Jewish Medical and Re-
search Center) to form the 3K–OVA conjugate. PE-labeled
IAb/3K tetramer was produced as described in our labora-
tory (29). Escherichia coli LPS was purchased from Difco.
Alum preparations were performed as previously described
(27). Schistosoma mansoni eggs were provided by Fred
Lewis (Biomedical Research Institute, Rockville, MD, USA).
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Injections
To follow Gr1+IL-4+ cells and to assay B cell Ca2+ responses
to alum or helminth products in both BALB/c and B6 strains,
WT or 4Get mice of both backgrounds were used. Age-
matched females between 6 and 10 weeks of age were
injected with 40 mg alum, S. mansoni eggs at indicated
doses or 200 ll PBS intra-peritoneally (i.p.). In experiments
designed to follow antigen-specific CD4 and antibody
responses, 10 lg 3K–OVA or OVA protein either prepared in
PBS, in combination with S. mansoni eggs, or precipitated
with alum was injected i.p. into WT or IL-4/ B6 mice. For
depletion of Gr1+ cells or neutralization of IL-4 in vivo, mice
were given 1 mg anti-Gr1 mAb, 500 lg anti-IL-4 mAb or pu-
rified rat IgG (Jackson ImmunoResearch Laboratories, Inc.)
by intravenous injection 1, 3 and 5 days after immunization.
Cell preparation
Spleens and peritoneal cells were harvested into cold bal-
anced salt solution (BSS) at indicated times after injection.
In some experiments, peritoneal cells were collected by
peritoneal lavage in BSS. Blood was collected in some
experiments and sera were stored at 20C until analysis
by ELISA. Splenocytes were processed into single-cell sus-
pensions using nylon mesh and red cells lysed with ammo-
nium chloride. Nucleated cells were enumerated using
a Coulter counter.
Flow cytometry
For analysis of Gr1+IL-4-expressing cells, peritoneal cells
from challenged IL-4 reporter mice were stained with reagents
against F480, cKit and Gr1 and splenocytes were stained with
reagents against CD4, CD8, B220 and Gr1. For analysis of
B cell Ca2+ responses in response to MHC II ligation, spleno-
cytes [107 ml1 in (Ca2+ free) Supplemented Minimum Es-
sential Media (SMEM) + 2.5% fetal bovine serum (FBS)]
were incubated with 10% 2.4G2 hybridoma supernatant, bio-
tinylated anti-MHC II antibody, 5 lM indo-1AM dye and fluo-
rochrome-labeled mAb against B220 for 45 min (37C in 5%
CO2). Cells were washed in SMEM–2.5% FBS, re-suspended
to 107 cells ml1 and allowed to rest 1 h at room temperature
(RT) prior to data acquisition on an LSR flow cytometer using
Cell Quest software (Beckton Dickenson). To cross-link MHC II
molecules, 5 lg ml1 extravidin (Sigma) was added to each
sample. Kinetic and population analysis of intracellular Ca2+
responses was performed using Flow-Jo software (Tree Star,
Inc.). To follow IAb/3K-specific CD4 cells, spleens were har-
vested 9 days after immunization. Splenocytes (1.25 3 107)
were added to the wells of 96 round well plates in 25 ll com-
plete tumor medium and stained with 3K/IAb tetramers as de-
scribed (29). APC–Cy7 anti-CD4, PB anti-B220, PB anti-F480,
Alexa405 anti-IAb and APC anti-CD44 were added at 4C for
20 min and cells were washed and analyzed immediately. Flow
cytometry data were acquired on a Cyan cytometer using
Summit software (Cytomation). Data were analyzed using
Flow-Jo software.
ELISAs
Ninety-six-well Immulon plates (Thermo) were coated with
OVA protein at 100 lg ml1 in PBS. Plates were washed us-
ing EL3405 Auto Plate Washer (BioTek Instruments) and
then blocked with 10% FCS/PBS for 2 h at RT. Plates were
washed and antibody serum samples diluted in 10% FCS/
PBS were added to the plates. To determine relative units,
we used a positive control pooled serum sample from B6
and BALB/c mice that contained OVA-specific Th2 and Th1
isotypes. The samples were incubated overnight at 4C.
Plates were washed and alkaline phosphatase-conjugated
anti-IgG1 (X56) or anti-IgG2a/c (R19-15) or biotinylated anti-
IgE (R35-119) (PharMingen) detection antibodies were added
for 2 h at RT. For IgE, alkaline phosphatase-conjugated
streptavidin was added for 1 h at RT. Substrate (p-nitrophenyl
phosphate) diluted in glycine buffer was added to each well
and 405 nm absorbance values were collected on El3808
microplate reader.
Statistics
Data are presented as indicated in the figure legends and
statistical significance determined using Student’s two-tailed
t-test with GraphPad Prism software version 4.
Results
A natural Th2-driving stimulus induces accumulation of similar
IL-4-expressing cells as alum
In mice injected with the adjuvant, alum, a population of in-
nate cells expressing intermediate levels of Gr1 (Gr1+) and
IL-4 accumulates in the spleen, reaching a peak 6 days after
alum administration (27). To determine whether a similar
population of cells accumulates in the spleen following expo-
sure to a ‘natural’ material that is known to induce Th2 re-
sponse, IL-4 transcriptional reporter (4Get) mice (30) were
injected with S. mansoni eggs, alum or PBS. CD4-positive
and CD4-negative cells in their spleens and the site of injec-
tion, the peritoneal cavities, were analyzed for GFP and Gr1
expression at various times thereafter. 4Get animals were
used because they express GFP under the control of the IL-
4 promoter and thus GFP expression by cells from these ani-
mals is an indication that their IL-4 locus is open (30).
Injection of either S. mansoni eggs or alum induced the
appearance of increased numbers of GFP+Gr1+ cells in
both locations over the time analyzed. The kinetics of accu-
mulation of GFP+Gr1+ cells in the spleen was much later
than the accumulation of GFP+Gr1+ cells in the peritoneal
cavity. In the peritoneal cavity, the peak accumulation of
GFP+Gr1+ cells occurred on day 1, while in the spleen ac-
cumulation of these cell peaked on day 6 [Fig. 1A and
(27)]. In the spleens, 6 days after injection, both alum and
S. mansoni eggs induced accumulation of CD4-negative
cells that co-expressed GFP (Fig. 1B, lower three panels).
These cells were found to be negative for B220, CD4 or
CD8, and in the spleen consisted of two different popula-
tions, a Gr1-negative population and a Gr1+ population
(Fig. 1B and data not shown).
In mice injected with S. mansoni eggs, an increased per-
centage of splenic CD4+ cells co-expressed GFP compared
with mice injected with PBS or alum particles alone (Fig. 1B,
top three panels). This is consistent with the known ability of
S. mansoni egg components to drive Th2 responses against
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intrinsic schistosome antigens. Although alum also is known to
drive Th2 responses, no antigen was included in these experi-
ments and so the alum was not expected to affect T cells. In
addition, GFP+ CD4+ cells did not co-express Gr1 (Fig. 1B).
Examination of cells at the site of injection after i.p. injec-
tion of alum or parasite eggs revealed that both stimuli in-
duced accumulation of IL-4-expressing cells in the
peritoneal cavity, as they did in the spleen. In the perito-
neum, the cells were relatively homogeneous since >95% of
these cells co-expressed Gr1 (Fig. 1C) and when sorted
were found to be >95% eosinophils (data not shown). In
contrast, only 50% of the Gr1+IL-4+ population in the spleen
were eosinophils while the remaining 50% have a mononu-
clear morphology (27).
Fig. 1. Schistosoma mansoni eggs, like alum, induce the appearance of Gr1+IL-4+ innate cells. (A) 4Get, IL-4 indicator mice were injected i.p.
with alum, S. mansoni eggs or PBS. At the indicated times, cells were isolated from the spleens and peritoneal cavities of the animals and stained
with antibodies against CD4, CD8, B220 and Gr1 (splenocytes) or F480, cKit and Gr1 (peritoneal cells). Shown are the means and standard
errors of numbers of B220-, CD4- and CD8-negative splenocytes or F480- and cKit-negative peritoneal cells that were Gr1+IL-4+ (GFP+) isolated
from three identically treated animals per group. (B) Expression of Gr1 and GFP (IL-4 mRNA) on CD4-negative or CD4-positive spleen cells
6 days after i.p. injection with alum, S. mansoni eggs or PBS. Numbers on graphs indicate the percentage of gated CD4 or CD4+ cells that fall
within the gates on each individual FACS plot. (C) FACS plots show Gr1 and GFP (IL-4 mRNA) expression on F4/80 cKit peritoneal cells from
mice injected 1 or 6 days previously with PBS, S. mansoni eggs or alum. Numbers on graphs indicate the percentage of F4/80 cKit cells that
fell within the gate on each plot for the sample shown. For (B and C), data are representative FACS plots from three individual mice per group.
Forty milligrams of alum or 104 S. mansoni eggs were used for injections in this experiment. Data are representative of three independent
experiments.
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Exposure to Th2-inducing stimuli increased MHC II-mediated
signaling in a large percentage of splenic B cells
Aggregation of antigen receptors on B cells or exposure of
B cells to IL-4 causes IgaIgb signaling chains to associate
with MHC II and thus enables MHC II, after cross-linking, to
transduce signals leading to mobilization of intracellular
Ca2+ and proliferation of the cells involved (28, 31). Recently,
we discovered that injection of alum into mice causes up-
regulation of MHC II expression and enhanced Ca2+ signals
after cross-linking of these receptors on B cells in their
spleens, a phenomenon which improves early IgM
responses to co-injected antigens (27). Since anti-Gr1 de-
pletion experiments implicated the Gr1+IL-4+ cells in this
phenomenon, we wondered whether the Gr1+IL-4+ cells in-
duced by S. mansoni eggs would have similar effects. Thus,
we injected C57Bl/6 (B6) mice i.p. with S. mansoni eggs or
alum and, 6 days later, tested the responses of the B cells
in their spleens to cross-linking of the MHC II proteins on
their surfaces. Like the B cells from alum-injected mice,
B cells from S. mansoni egg-injected mice contained elevated
concentrations of cytoplasmic Ca2+ in response to MHC II
cross-linking when compared with B cells from untreated
mice (Fig. 2A). In each mouse, we also compared the per-
centage of B220+ cells that fluxed Ca2+ at the peak of the
response to MHC II cross-linking with the percentage that
fluxed Ca2+ in the absence of stimulus. In mice that had
been injected 6 days prior with alum or S. mansoni eggs,
there was an up to 2.5-fold increase in the percentage of
B cells fluxing Ca2+ than in untreated control mice (Fig. 2C).
We did a dose response and found at least 104 S. mansoni
eggs had to be injected to observe the effects on MHC
II-mediated signaling (Fig. 2B). Thus, the polyclonal effects
on B cells that we have previously found to accompany the
presence of enhanced numbers of IL-4-expressing cells in
mice exposed to alum also occurred in mice exposed to hel-
minth products.
Depletion of Gr1+ or IL-4-expressing cells eliminated the
in vivo effects of S. mansoni eggs or alum exposure on
splenic B cell signaling
We have previously shown that IL-4 neutralization blocks the
ability of alum to promote enhanced MHC II signaling in
splenic B cells. To find out whether IL-4 is required for these
polyclonal effects on B cells in response to S. mansoni eggs,
IL-4/ and WT B6 mice were injected with S. mansoni eggs
i.p. and MHC II-mediated Ca2+ responses in splenic B cells
were analyzed 6 days later. In contrast to the high MHC II-
induced Ca2+ flux that occurred in B cells from S. mansoni
egg-injected WT mice, intracellular Ca2+ levels increased
only slightly following MHC II aggregation on B cells from
egg-injected IL-4/ mice (Fig. 3A) and S. mansoni egg in-
jection did not increase the percentage of B cells that fluxed
Ca2+ in IL-4/ mice as it did in WT mice (Fig. 3B). These
data suggest that helminth products, like alum, mediate poly-
clonal effects on B cells via an IL-4-dependent mechanism.
Alum cannot promote MHC II-mediated signaling in B
cells if Gr1+ cells are removed with a Gr1-depleting antibody
(27). To determine whether a Gr1-expressing cell type is
involved in S. mansoni egg-induced effects on MHC
II-mediated Ca2+ responses in B cells, we injected S. man-
soni eggs into B6 mice that had been treated either with
anti-Gr1 antibodies or with control rat IgG. We observed that
after treatment with anti-Gr1 antibodies, MHC II cross-linking
neither induced Ca2+ fluxes nor increased the percentage of
B cells that increased their levels of intracellular Ca2+
(Fig. 3C and D). Thus, Gr1+IL-4+ cells probably play a role
in polyclonal B cell effects induced by S. mansoni eggs, just
as they do during responses to alum.
Fig. 2. MHC II-mediated Ca2+ responses in B cells are enhanced after
exposure to Th2 stimuli. (A) Spleen cells were isolated from mice
injected 6 days previously with nothing (gray histogram), 104
Schistosoma mansoni eggs (bold black histogram) or alum (fine black
line histogram) and stained as described in Methods. MHC
II molecules on the surface of the cells were cross-linked with
biotinylated anti-MHC II followed by avidin. The time of addition of
avidin is indicated on the figure by the arrow. Shown are the changes in
intracellular Ca2+ levels in B220+ cells. (B) Mice were given the
indicated numbers of S. mansoni eggs. Six days later, spleen cells
from the mice were stained and their MHC II molecules cross-linked as
described in Fig. 1(A). Shown are the changes in intracellular Ca2+
induced by the cross-linking. Data in (A and B) are representative of
three mice per group in a single experiment. (C) Shown are the
percentage of B220+ cells undergoing Ca2+ flux in the absence of any
stimulation (white bars), after addition of anti-MHC II mAb but before
avidin-mediated cross-linking (gray bars) and during the peak of the
response after addition of avidin (solid bars) in mice injected 6 days
previously with S. mansoni egg, alum or PBS. Means6 standard errors
for values from three mice are shown and asterisks indicate results that
differed from those in naive mice with P < 0.05 (*) or P < 0.01 (**). Data
in this figure are from a representative experiment of three.
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Alum promotes expansion of CD4 cells to co-injected antigen
but S. mansoni eggs do not
The enhanced ability of B cells to signal downstream of
MHC II engagement could improve their ability to present
antigen, thereby affecting the CD4 T cell response. To test
this, we decided to compare the effects of alum and S. man-
soni eggs on T cell priming. In the past, such experiments
have been done by following the consequences of T cell ac-
tivation, such as helper function or cytokine release. How-
ever, here we wanted to measure T cell numbers. Such
experiments can be performed by transfer of T cells
expressing transgenic (Tg) TCRs, but artifacts have been
associated with the use of fairly large populations of these
cells, bearing a single TCR. In fact, we have noticed that
such cells may not be good representatives of endogenous
host T cells. For example, if too many TCR Tg T cells were
transferred, they did not all increase their surface CD44 and
differentiate into Th2, in mice given antigen + alum. To cir-
cumvent these problems, we decided to follow endogenous
T cells specific for IAb bound to the 3K peptide, a combina-
tion for which excellent staining tetramers can be made. To
allow us to follow both antibody and CD4 T cell responses,
the 3K peptide was conjugated to OVA (3K–OVA). This com-
bination still allowed presentation of 3K to T cells and OVA to
B cells, since 3K–OVA induced the rapid expression of
CD69 on IAb/3K-specific T cells in vitro, induced anti-OVA
antibodies, detected by ELISA, in immunized mice and
could be used to detect anti-OVA antibodies in capture
ELISA reactions (data not shown).
We have estimated that naive B6 mice contain 50–100
T cells specific for IAb/3K (M. MacLeod, unpublished data).
The numbers of IAb/3K-specific CD4 T cells peak 9 days af-
ter injection of 3K–OVA when either alum or LPS was used
as adjuvant (M. MacLeod and A. McKee, unpublished data).
Administration of 3K–OVA bound to alum, rather than free
3K–OVA alone, greatly increased the numbers of 3K-specific
T cells in the spleen at this time (Fig. 4). We were surprised
to find that alum promoted priming of CD4 cells as well as
LPS, a TLR agonist often used as an adjuvant (32, 33). In con-
trast, there was no difference in the percentage or total num-
ber of IAb/3K-specific CD4 cells detected in the spleens of
mice injected with 3K–OVA in the presence or absence of
S. mansoni eggs (Fig. 4). Thus, the bystander enhancement
of MHC II-mediated signaling in B cells, which occurs in the
S. mansoni egg-injected animals, is not sufficient for enhanced
CD4 priming to co-injected antigen. This implies that alum
greatly promotes CD4 priming through another mechanism.
Enhanced CD4 priming by alum adjuvant is independent of
Gr1+ and IL-4-expressing cells
Both alum and helminth eggs promoted recruitment of IL-4-
expressing innate cells in the spleen, but only alum en-
hanced CD4 priming to co-injected antigen. To test directly
whether or not the presence of Gr1-expressing cells affects
CD4 priming, we injected B6 mice with 3K–OVA in the pres-
ence or absence of alum, treated them with either a Gr1-
depleting antibody or control rat IgG and determined the
number of IAb/3K-specific CD4 T cells in the spleen 9 days
later. We found a similar number of activated IAb/3K-specific
CD4 T cells in the spleens of 3K–OVA/alum-injected mice
whether or not the mice were treated with the Gr1-depleting
antibody (Fig. 5A and B).
This experiment did not test the need for IL-4 in T cell
priming since Gr1+ cells are not the only cells induced by
Fig. 3. The effects of Schistosoma mansoni egg or alum on B cells
are dependent upon IL-4- and Gr1-expressing cells. (A) WT and
IL-4/ mice were injected i.p. with nothing (fine black line) or
S. mansoni eggs (bold black lines). Six days later, spleen cells were
isolated and stained and MHC II cross-linked as described in Fig. 2.
Shown are the changes in intracellular Ca2+ levels in B220+ cells after
MHC II cross-linking. (B) WT or IL-4/ mice were injected with
nothing or S. mansoni eggs and analyzed 6 days later as described in
(A). Graphs show the percentages of splenic B220+ cells from naive,
S. mansoni egg-injected WT or IL-4/ mice that fluxed Ca2+ before
(white bars) and during the peak (black bars) of the response to
avidin-mediated cross-linking of their MHC II molecules. (C)
Mice were injected i.p. with nothing (gray lines), alum or S. mansoni
eggs (black lines). Alum- or S. mansoni egg-injected mice were
treated with either control rat IgG (bold black lines) or anti-Gr1
mAb (fine black lines). Six days after alum or S. mansoni egg
injection, spleen cells were isolated and their MHC II molecules cross-
linked as described in Fig. 2. Shown are the changes in intracellular
Ca2+ levels in B220+ cells after MHC II cross-linking. (D) Mice were
injected with nothing, S. mansoni eggs or alum, later with control rat
IgG or anti-Gr1 and their spleen cells analyzed 6 days after injection
of S. mansoni eggs or alum as described in (C). Shown are the means6
standard errors of the percentages of B220+ cells that had increased
levels of intracellular Ca2+ before (white bars) or after (black bars)
cross-linking of their MHC II proteins. Asterisks indicate a group with
a percentage of cells fluxing Ca2+ after MHC II cross-linking that was
significantly different from that observed in cells from naive mice (P <
0.05). Results in (A and C) are representative of two individual
experiments and data in (B and D) are from a representative
experiment of three.
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alum that can produce the cytokine (Fig. 1A). Thus, to exam-
ine this issue, WT or IL-4/ mice were injected with 3K–
OVA in the presence or absence of alum and the numbers
of IAb/3K-specific CD4 T cells counted 9 days later. The ab-
sence of IL-4 had no effect on the percentage or number of
IAb/3K-specific cells detected in the spleens of mice
injected 9 days previously with 3K–OVA/alum (Fig. 5C and
D). Moreover, the fold increase of such cells in mice that
had been injected with 3K–OVA/alum versus those in mice
that received 3K–OVA alone was similar between the two
types of mice. These results show that, as previously
reported, the ability of alum to increase T cell primary
responses does not involve IL-4.
Depletion of Gr1+ cells results in increased levels of Th1-
associated antibody isotypes
Alum increases the primary T cell response to antigen. How-
ever, even on the peak day, animals given alum plus 3K–
OVA still contained only rare cells specific for IAb/3K. Be-
cause of this, it has been difficult to assess by intracellular
staining whether the cells induced in such experiments are
Th1 or Th2 in nature. Therefore, to examine the effects of
Gr1 depletion on the phenotype of the primed CD4 cells,
we tracked antigen-specific CD4 cells in alum-injected 4Get
mice. We found that the percentage of IAb/3K-specific cells
that had the potential to make IL-4 was significantly larger
in animals given antigen plus alum (Fig. 6A). This effect
combined with the strong effect of alum on CD4 expansion
(Fig. 4) resulted in greatly enhanced numbers of IAb/3K-
specific, IL-4-expressing CD4 cells in 3K–OVA/alum-injected
mice (Fig. 6B). Moreover, treatment of immunized mice with
anti-Gr1 did not affect the percentage or total number of
IAb/3K-specific cells capable of making IL-4 (Fig. 6A and B).
The phenotype of T cells affects the isotypes of antigen-
specific antibodies produced during immune responses.
Th2-driven responses are characterized by high levels of
IgE and IgG1 while responses involving Th1 are character-
ized by elevated production of IgG2a/c isotypes. Mice
injected with OVA/alum contained high levels of IgG1 anti-
OVA antibodies compared with mice that received OVA
alone (Fig. 6C). These titers were not affected by treatment
with anti-IL-4 antibodies or removal of Gr1+ cells during the
first week of the primary response. We did not observe
OVA-specific IgE levels in these B6 mice at this time point.
As expected, OVA antigen given with CFA induced large
amounts of IgG2c anti-OVA (Fig. 6D). Not unexpectedly,
given the Th2 phenotype of the T cell response, titers of
IgG2c anti-OVA antibodies were only slightly elevated in
mice given OVA/alum versus OVA alone (Fig. 6D). In this
case, however, as has been shown in IL-4-deficient mice
(23), anti-IL-4 dramatically increased the ability of OVA to in-
duce IgG2c antibodies, and surprisingly anti-Gr1 had a simi-
lar, although not quite so dramatic effect (Fig. 6D). We found
a similar effect of Gr1 depletion in mice that had been immu-
nized with OVA adsorbed to a commercial form of alum,
AlhydrogelTM. In addition, we saw a similar effect of Gr1 de-
pletion on antibody isotypes in BALB/c mice (Fig. 6E). While
OVA-specific IgG2a levels were elevated in mice treated
with Gr1-depleting antibody, OVA-specific IgG1 and IgE
levels in these mice were unaffected by Gr1 depletion
(Fig. 6E). In combination with the T cell results (above),
these data suggest that the ability of alum to preclude Th1-
like responses depends, to some extent, on Gr1+ cells and
IL-4 production.
Discussion
It is known that helminth products and alum have overtly
similar effects on the immune response. Both stimulate
strong Th2 responses and elicit high levels of IgE and IgG1
against associated antigens (10, 12, 13). Others have there-
fore suggested that the two substances may promote Th2
responses in a similar way (34). The ability of these two quite
different materials to have similar effects on the innate
Fig. 4. Alum but not Schistosoma mansoni eggs promotes enhanced
CD4 responses to co-injected antigen. (A) B6 mice were injected with
3K–OVA protein combined with nothing (), S. mansoni eggs, alum or
7 lg LPS and splenocytes were stained with antibodies against B220,
F480, CD44, CD4 and IAb/3K tetramers 9 days later. Plots show
staining with anti-CD44 and IAb/3K tetramers on CD4-positive, F4/
80 B220 spleen cells. Numbers on graphs indicate the mean
percentages of CD4 cells that were CD44hi IAb/3K tetramer positive
for the sample shown. Data shown are representative of three
identically treated mice in each group. Cells that stained as CD44hi
and with IAb/3K tetramer in naive mice illustrate the level of
background staining in these experiments. (B) Shown are the means 6
standard errors of the numbers of IAb/3K-specific CD44hi CD4 T cells
detected per spleen for three mice per group. Asterisks indicate
samples in which the numbers of IAb/3K-specific T cells that were
detected were significantly different from the numbers detected in
mice injected with 3K–OVA alone (P < 0.05). Data are from
a representative experiment of three.
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immune system suggests that they are somehow recognized
via similar pathways early after exposure. Many adjuvants
activate innate immune responses via engaging TLRs; how-
ever, the effects of alum on antibody responses are indepen-
dent of MyD88 and TRIF, essential signaling components
downstream of TLRs (8, 9). Likewise, other studies have indi-
cated that Th2 responses in response to S. mansoni are
largely TLR independent (35). Therefore, both alum and
S. mansoni eggs appear to act as Th2-driving adjuvants in-
dependently of TLRs and must act via some other sets of
receptors. Alum and S. mansoni eggs may act via the same
receptor or, alternatively, they may be first detected by differ-
ent receptors that converge on the same Th2-inducing path-
way. Other products that induce a similar type 2
inflammation, such as chitin (36), may converge on these
same receptors and/or intracellular signaling pathways.
Here, we show that S. mansoni eggs and alum activate
similar innate immune responses. When injected i.p., both
cause the accumulation of Gr1+IL-4-producing cells in the
spleen and peritoneum. Via a process that requires these
cells, both substances promote changes in B cells in the
spleen to respond with intense Ca2+ fluxes to cross-linking
of their MHC II molecules. These shared effects on the in-
nate immune system are apparent within 24 h of administration;
therefore, responses to the two products converge quickly
and are not due to later downstream effects.
The two materials do not share all properties since alum,
but not S. mansoni eggs, acts as an adjuvant, improving
T and B cell responses to co-injected antigen. At first sight,
this is an unexpected result since others have shown that
a Lewisx-containing oligosaccharide on S. mansoni eggs,
lacto-N-fucopentaose III (LNFPIII), bound to proteins, helps
B cell production of Th2-driven antibodies and S. mansoni
eggs induce powerful antibody responses against their own
antigens (37). We believe that the contradictions are related
to whether or not the co-administered antigen is physically
associated with the intrinsic adjuvant within S. mansoni
eggs. Many proteins bind well to alum, and the reported ad-
juvant effects of LNFPIII are on responses to covalently
linked antigens. In the experiments described here, in which
S. mansoni eggs failed to act as good adjuvants, the eggs
and antigen were injected at the same site, but not bound
to each other. Therefore, we predict that the abilities of
S. mansoni eggs or alum to improve immune responses proba-
bly depend on their being taken up together with the antigen
by the same cell. The adjuvant effects of helminth products
described elsewhere, and, by extension, alum may then be
mediated by direct effects of the materials on the properties
Fig. 5. The ability of alum to enhance expansion of antigen-specific CD4 cells is independent of Gr1-expressing cells and IL-4. (A and B) C57BL/6
mice were injected with 3K–OVA either alone or adsorbed to alum and treated with either rat IgG or anti-Gr1 as described in Methods. Nine days
later, splenocytes were stained as in Fig. 4. (A) The FACS plots show the staining of F4/80 B220 CD4+ cells with anti-CD44 and IAb/3K
tetramer. Numbers indicate the percentages of F4/80 B220 CD4+ cells that were CD44hi and IAb/3K tetramer positive and are representative
of three individual samples. (B) Shown are the averages 6 standard errors of the numbers of CD44hi IAb/3K-staining CD4+ cells per spleen of
mice immunized as indicated. Results are representative of three independent experiments. (C and D) WTor IL-4/mice were injected with 3K–
OVA with or without alum. Nine days later, their spleen cells were isolated and analyzed as in (A and B). Results are representative of two
separate experiments.
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of the antigen-presenting cells. This idea is supported by the
fact that alum and extracts from S. mansoni eggs have simi-
lar effects on DCs, modulating the outcome of TLR engage-
ment in the cells, inducing DCs to promote Th2 responses
without elevating certain co-stimulatory proteins or promot-
ing production of IL-12 (16–18, 38, 39).
Others have previously shown that IL-4 and IL-13 are not
required for alum to prime good Th2 responses but do play
a role in suppressing Th1-related cytokine production after
exposure to antigen plus alum (23, 24). Here, we confirm
those observations and extend them by showing that the
Gr1+ cells induced by the adjuvant have parallel effects.
Like IL-4, they are not required for alum to improve T cell
priming and, also like IL-4, they do suppress the ability of
alum to induce Th1-driven responses such as production of
antibodies of the IgG2a/c isotype. These results suggest that
the Gr1+ cells may be an important source of the IL-4 that
suppresses the type 1 responses. Strategies that prevent
production of such cells during vaccination with alum might
actually improve the efficacy of the vaccine, broadening the
classes of antibody produced without reducing the titer.
Previously, others have shown that IL-4/ mice injected
with alum have Th2 responses that are somewhat reduced
by comparison with those of WT mice (23). Here, we found
Fig. 6. Gr1+ cells and IL-4 inhibit production of Th1-induced antibody isotypes. (A and B) 4Get mice were injected with 3K–OVA with or without
alum and were treated with either control rat IgG or anti-Gr1 mAb as described in Methods. Splenocytes were stained for the presence of IAb/3K-
specific CD4 Tcells and gates were drawn around CD44hi IAb/3K+ CD4 cells as in Figs 4 and 5. (A) Shown are the average 6 standard errors of
the percentages of IAb/3K+ CD44hi CD4+ spleen cells that expressed GFP (IL-4 mRNA). The results are from three identically treated mice per
group. (B) Shown are the average numbers6 standard errors of GFP+ IAb/3K+ CD44hi CD4+ cells per spleen from mice immunized as indicated.
The results are from three identically treated mice per group. (C and D) B6 mice were injected with OVA with or without alum or CFA. Mice were
treated with IgG (white bars), anti-Gr1 (gray bars) or anti-IL-4 (black bars) on days 1, 3 and 5 after primary immunization. On day 9, mice were
injected with OVA alone and on day 12 their sera were tested for OVA-specific antibodies by ELISA as described in Methods. The results
represent the mean relative units 6 standard errors of OVA-specific antibody detected from three individual mice per group. Asterisks indicate
groups in which the amount of antibody detected was significantly different from that in similarly immunized mice that received control IgG; *P <
0.05, **P < 0.01 and ***P < 0.001. Results are representative of two independent experiments. (E and F) BALB/c mice (E) or B6 mice (F) were
injected with either alum (E) or Alhydrogel (F)-adsorbed OVA and were treated with IgG (white bars) or aGr1 (black bars) antibody as above. On
day 10, mice were boosted with alum-adsorbed OVA and sera were tested for OVA-specific isotypes 5 days later. Results are representative of
three (E) and two (F) individual experiments.
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that although depletion of IL-4 on days 1, 3 and 5 of the pri-
mary response was sufficient to prevent suppression of Th1-
dependent antibodies, it had no effect on the amount of
IgG1 produced, a result which appears to contradict the
previous observations (23). The difference may lie in the fact
that the T cells in the IL-4/ mice had never been exposed
to IL-4, and IL-4 may have some effect on T cells before they
respond overtly to antigen, since naive T cells can detect the
cytokine (40, 41). Thus, pre-exposure to IL-4 may have some
effect on the ability of T cells to differentiate into Th2,
whereas acute lack of IL-4, just during response to antigen,
may affect only the ability to suppress type 1 responses.
In other systems, similar effects of Gr1+ cells have been
observed; for example, Gr1+ cells accumulate in secondary
lymphoid organs during sepsis and depletion of these cells
resulted in elevated Th1 responses (42). In other studies,
Gr1+ cells were found to be accumulated after exposure to
parasites and have a suppressive effect on the proliferation
of CD4 cells (43). The effects of Gr1+ cells seen here are un-
likely to occur by suppressing proliferation of CD4 cell, how-
ever, because total numbers of IAb/3K-specific CD4 cells were
unaffected in 3K–OVA-injected mice, depleted of Gr1+ cells.
In summary, here we show that alum and S. mansoni eggs
have similar effects on innate IL-4-producing cells. Via these
cells, alum and probably also S. mansoni eggs suppress
Th1-related immune responses, leaving the host with only
Th2-related immunity. Further understanding of the mecha-
nisms by which this occurs could lead to development of
vaccines that induce a less Th2-biased immune response.
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Abbreviations
AF Alexa Fluor
BSS balanced salt solution
Ca2+ calcium
DC dendritic cell
FBS fetal bovine serum
GFP green fluorescence protein
i.p. intra-peritoneally
LNFPIII lacto-N-fucopentaose III
OVA ovalbumin
RT room temperature
Tg transgenic
TLR Toll-like receptor
WT wild type
APC allophytocyanin
PB pacific blue
PE phytoerythrin
SMEM supplemented minimum essential media
RU relative units
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